Referencias Bibliográficas
Kiani AK, Paolacci S, Calogero AE, Cannarella
R, Di Renzo GC, Gerli S, Della Morte C, Busetto GM, De Berardinis E, Del
Giudice F, Stuppia L, Facchinetti F, Dinicola S, Bertelli M. From Myo-inositol
to D-chiro-inositol molecular pathways. Eur Rev Med Pharmacol Sci. 2021
Mar;25(5):2390-2402. doi: 10.26355/eurrev_202103_25279. PMID: 33755975.
Lete I, Martínez A, Lasaga I, Centurión E,
Vesga A. Update on the combination of myo-inositol/d-chiro-inositol for the
treatment of polycystic ovary syndrome. Gynecol Endocrinol. 2024
Dec;40(1):2301554. doi: 10.1080/09513590.2023.2301554. Epub 2024 Jan 18. PMID:
38239032.
Laganà AS, Garzon S, Casarin J, Franchi M,
Ghezzi F. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a
Pathophysiology-Based Approach. Trends Endocrinol Metab. 2018
Nov;29(11):768-780. doi: 10.1016/j.tem.2018.09.001. Epub 2018 Sep 27. PMID:
30270194.
Zia A,
Farkhondeh T, Pourbagher-Shahri AM, Samarghandian S. The role of curcumin in
aging and senescence: Molecular mechanisms. Biomed Pharmacother. 2021
Feb;134:111119. doi: 10.1016/j.biopha.2020.111119. Epub 2020 Dec 24. PMID:
33360051.
Alnahdi
A, John A, Raza H. N-acetyl cysteine attenuates oxidative stress and
glutathione-dependent redox imbalance caused by high glucose/high palmitic acid
treatment in pancreatic Rin-5F cells. PLoS One. 2019 Dec 20;14(12):e0226696.
doi: 10.1371/journal.pone.0226696. PMID: 31860682; PMCID: PMC6924679.